We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Precision Surgery System for Early-Stage Lung Cancer Provide Surgeons with Real-Time GPS Guidance

By HospiMedica International staff writers
Posted on 18 Sep 2023
Print article
Image: The NaviSci System is designed to provide GPS navigation for precise margin control (Photo courtesy of Navigation Sciences)
Image: The NaviSci System is designed to provide GPS navigation for precise margin control (Photo courtesy of Navigation Sciences)

Lung cancer ranks high among global causes of death. Fortunately, more cases—especially of the most common type, non-small cell lung cancer—are being detected at early stages like Stage 1 and Stage 2. At these stages, surgical intervention can yield promising long-term results. Now, a new system designed for use in the precision surgical treatment of early-stage lung cancer provides surgeons with real-time ‘GPS’ guidance during minimally invasive surgery. Designed to address the growing need to locate and remove lung and other soft tissue cancers, the system determines real-time margin measurement, reduces local recurrence risk, and minimizes removal of lung tissue in order to preserve lung function.

Navigation Sciences (Brookline, MA, USA) is developing the NaviSci System for use in the precision surgical treatment of early-stage lung cancer. The system offers surgeons a kind of 'GPS' to pinpoint the exact location of both the tumor and adjacent tissue during surgery, and then suggest where to excise the tumor. The system is the first to measure surgical margins in real-time, thereby greatly improving the precision of tissue removal. The NaviSci System includes an active fiducial marker known as a J-Bar, which is positioned next to the tumor. This marker helps to localize the tumor's position and map out the shortest access route from the lung surface to the cancerous nodule.

The system also comes with a specialized surgical cutting tool that has its own position sensor, along with dedicated software that syncs the sensors on both the J-Bar and the cutting tool. This gives surgeons both visual and numerical data to determine tumor margins in real-time, allowing for more accurate removal of the cancer while preserving surrounding healthy lung tissue. Additionally, Navigation Sciences is also working on the NaviSci EndoMarker, a bronchoscope-based marker designed to simplify the pre-surgery process. The system positions the J-Bar marker next to the tumor through the endoscope's working channel, using navigational and diagnostic CT images for guidance. The NaviSci System holds huge potential due to the rising cases of early-stage lung cancer and the increasing adoption of minimally invasive surgical methods that have demonstrated effectiveness similar to traditional surgery types like lobectomy.

Related Links:
Navigation Sciences 

Gold Member
12-Channel ECG
CM1200B
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgical Planning Software and Guide
Signature ONE Surgical Planning

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.